Schriftgröße: 100 %
Article 1
Rhône-Poulenc Biochimie SA, Aventis Pharma SA and Merck KgaA have infringed Article 81(1) of the Treaty and, from 1 January 1994 onwards, Article 53(1) of the EEA Agreement by participating in a continuing agreement and/or concerted practice in the methylglucamine sector.
The duration of the infringement was for all three addressees 22 November 1990 until 31 December 1999.
